Cardiac function and quality of life improvement with fasudil hydrochloride in patients with diabetes post-PCI: a randomized controlled trial
Objective We assessed the efficacy of fasudil hydrochloride, a Rho-kinase inhibitor, as adjunct therapy for enhancing cardiac function, managing blood sugar, and improving quality of life in patients with diabetes who have coronary heart disease (CHD) and who underwent percutaneous coronary interven...
Saved in:
Main Authors: | Xuejia Yang, Qian Li, Yaning Liu, Ran Chen, Yanjing Liu, Chenghui Sun, Licha Kong, Qiuli Dong |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2025-02-01
|
Series: | Journal of International Medical Research |
Online Access: | https://doi.org/10.1177/03000605241311403 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of exercise-based cardiac rehabilitation on cardiopulmonary function and prognosis in ST elevation myocardial infarction after PCI patients in extremely cold regions
by: Shenglong Hou, et al.
Published: (2025-02-01) -
Triglyceride-glucose index is associated with microcirculatory resistance in patients with type 2 diabetes and STEMI undergoing primary PCI
by: Guoyu Wang, et al.
Published: (2025-02-01) -
A multicenter, randomized, open label, two formulation, crossover bioequivalence trial of doxorubicin hydrochloride liposomal injection in Chinese patients with metastatic breast cancer
by: Jingshu Wang, et al.
Published: (2025-01-01) -
Association between echocardiographic parameters of cardiac structure and function and mild cognitive impairment
by: Kai Zhang, et al.
Published: (2025-02-01) -
OOxytetracycline Hydrochloride (OTC-HCl) Application for Control of Palm Phytoplasmas
by: Brian W. Bahder, et al.
Published: (2019-04-01)